Policy and Legislation
The amendment would give funding to the Department of Health and Human Services to require drug pricing in direct-to-consumer advertising.
The pharma industry is skating to where they know the puck is going on drug price transformation, HHS Secretary Alex Azar says.
Bipartisan Policy Center recommends CMS give MA plans flexibility in targeting supplemental benefits to members with chronic care conditions.
Teva Pharmaceuticals is marketing the first approved generic epinephrine auto-injector for the emergency treatment of allergic reactions.
States are required to get CMS approval for any changes they want to make to their Medicaid programs, no matter how simple.
Competition drives drug prices and results in higher rebates, insurance organization says.
OptumRx is changing its medication containers for temperature-sensitive prescriptions for home delivery to renewable cotton that is biodegradable, compostable, reusable and recyclable.
HRSA is distributing the funds to help boost the use of technology to improve efficiencies and outcomes among small hospitals.
Prosecutors for the 10 regional strike forces currently in operation have charged over 3,700 defendants in connection to more than $14 billion in false billings, DOJ says.
Site-neutral clinic payments, 340B drug program policy, adding procedures to covered list for ambulatory surgery centers all hit hospital margins.